Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22159,168,1.19 [0.95-1.50],0.1316441523910222
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23159,185,1.18 [0.95-1.48],0.1430225256557749
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22920,1374,1.11 [1.02-1.20],0.0143730302784166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Candidiasis,23172,364,1.21 [1.04-1.42],0.014837372809261
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22495,3384,1.10 [1.04-1.16],0.0003982252536584
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22461,3400,1.12 [1.07-1.19],1.4230041527688968e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22962,1025,1.08 [0.98-1.19],0.1168639381322354
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23097,81,0.91 [0.64-1.31],0.6271028246791452
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20999,1081,1.19 [1.08-1.30],0.0002908445390183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20265,1200,1.20 [1.10-1.31],4.7748602316635055e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20000,241,1.28 [1.06-1.54],0.0114576676114543
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16295,2210,1.09 [1.02-1.17],0.0092065369609877
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19930,394,1.19 [1.02-1.38],0.0271724211370311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23159,1222,1.09 [1.00-1.19],0.0529627764933138
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Mycoses,23259,451,1.21 [1.05-1.40],0.0069070285059281
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22418,872,1.11 [1.00-1.24],0.0418586954457529
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23183,1192,1.17 [1.07-1.27],0.0005614730599531
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22124,187,1.17 [0.93-1.46],0.1715985082397945
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23297,50,1.10 [0.71-1.71],0.6589202790051969
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23033,1042,1.16 [1.06-1.28],0.0016177752583114
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23083,67,1.39 [0.98-1.97],0.0637673528198393
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23240,117,1.18 [0.90-1.56],0.2322018299393451
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23220,97,1.23 [0.91-1.66],0.1728485558372519
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22020,474,1.18 [1.03-1.36],0.0159967244836204
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21825,279,1.09 [0.90-1.31],0.3726692396343515
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22024,87,1.29 [0.94-1.76],0.1127462873889095
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23278,68,0.80 [0.54-1.20],0.275835145313876
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23241,141,1.05 [0.81-1.36],0.730849027490993
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral warts,23152,52,1.31 [0.88-1.96],0.180379895147736
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23150,50,0.83 [0.52-1.33],0.4393254386421326
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm,22987,333,0.92 [0.77-1.09],0.3271842863809229
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23228,46,0.77 [0.47-1.26],0.2998598300896177
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23193,51,0.80 [0.51-1.28],0.3583849815010654
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23250,128,1.07 [0.81-1.41],0.6295877192324426
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22936,1597,0.98 [0.90-1.06],0.5932626161364127
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of meninges,23298,32,1.11 [0.65-1.92],0.6988510591919691
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23234,63,1.59 [1.15-2.22],0.0055218511266919
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23283,76,1.64 [1.22-2.20],0.0010639605026366
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23273,431,1.08 [0.93-1.26],0.3045208092802577
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Caecum,23267,336,0.99 [0.83-1.17],0.8844240626933586
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23174,81,1.06 [0.75-1.49],0.7597150346474584
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Descending colon,23265,270,0.97 [0.80-1.17],0.7434122606053222
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Rectum,23227,410,0.94 [0.81-1.11],0.4766818804854077
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23174,706,0.90 [0.80-1.02],0.0870662851378668
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23254,542,1.05 [0.92-1.20],0.4605513982249311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18109,70,1.33 [0.94-1.88],0.1117639762993142
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18106,67,0.97 [0.65-1.44],0.873752228891435
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23266,96,1.08 [0.79-1.48],0.6358512650984924
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma, any site",23266,93,1.11 [0.81-1.52],0.5272333529161172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lung cancer and mesothelioma,15512,337,1.36 [1.17-1.60],0.0001139261831356
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lymphoid leukaemia,18103,64,1.64 [1.19-2.27],0.0028020133838148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18233,194,1.07 [0.85-1.34],0.5817411660016847
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18323,284,0.98 [0.81-1.19],0.8252789643523517
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18125,86,1.10 [0.79-1.53],0.5720767444285275
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18178,139,1.24 [0.96-1.59],0.1026897594119299
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18177,138,0.87 [0.66-1.15],0.3283684682957346
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18119,80,0.90 [0.62-1.29],0.5538830926334788
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19406,1367,1.00 [0.92-1.09],0.9992598140081236
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18182,143,0.97 [0.74-1.27],0.8257263556385468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18141,102,1.42 [1.07-1.87],0.0145991541635942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18163,124,1.02 [0.76-1.35],0.9103730016457748
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi,23173,164,0.85 [0.66-1.10],0.2088267714043062
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi of trunk,23265,90,0.95 [0.67-1.33],0.7454714502119106
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanoma in situ,18071,70,0.89 [0.60-1.32],0.5581604015588844
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18134,95,0.90 [0.65-1.27],0.5590982496782684
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18197,158,1.10 [0.86-1.42],0.4352481428546867
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18254,215,1.23 [1.00-1.50],0.0469881871359833
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18135,96,1.07 [0.77-1.48],0.6829073976686406
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Other benign neoplasms of skin,23168,133,1.10 [0.84-1.43],0.5055088221740376
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19211,1172,1.05 [0.95-1.15],0.3416715077802162
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19283,1244,1.03 [0.94-1.13],0.482080971071004
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23027,299,1.11 [0.93-1.32],0.2626005393663317
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21620,115,1.52 [1.19-1.96],0.0009097592534653
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22798,70,1.31 [0.93-1.85],0.1262543463540433
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22760,2712,1.12 [1.05-1.18],0.0003093291036938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22052,60,1.38 [0.96-1.99],0.0814863246560542
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22891,52,0.68 [0.42-1.09],0.1084314140033212
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22934,1429,1.10 [1.01-1.19],0.0224019024501798
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22932,1427,1.10 [1.01-1.19],0.023649078521517
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21605,100,1.04 [0.76-1.42],0.8226812905003434
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23066,1074,1.33 [1.21-1.45],3.63071159078774e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22940,101,0.99 [0.72-1.35],0.9314884447069076
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22804,76,0.82 [0.56-1.19],0.2923675099596602
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22789,61,1.26 [0.86-1.84],0.2364480678256071
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23142,303,0.80 [0.66-0.96],0.0191660652881532
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23205,49,0.97 [0.62-1.53],0.9005093223973047
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23083,244,0.75 [0.61-0.93],0.0087467120663564
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22068,76,0.81 [0.55-1.19],0.2784369811192188
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17188,372,1.31 [1.12-1.53],0.00059264489916
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21304,164,0.77 [0.59-0.99],0.0445746738595662
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21326,186,0.70 [0.55-0.90],0.0049078278342689
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,16873,57,0.90 [0.59-1.39],0.6398189104095184
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21952,63,0.66 [0.43-1.02],0.0591844619606659
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21206,215,1.07 [0.86-1.32],0.5589258149900279
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22802,600,1.10 [0.97-1.24],0.1545719407297248
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22443,241,0.89 [0.72-1.09],0.2600439107949086
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22365,163,1.14 [0.89-1.45],0.297505110957222
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23002,1113,1.24 [1.14-1.36],9.637728024964918e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19936,1072,1.23 [1.13-1.35],4.274750023614446e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",16885,69,1.18 [0.81-1.71],0.3859234328944601
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22430,38,0.96 [0.57-1.60],0.8625683206923254
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17089,273,1.28 [1.07-1.54],0.0071067368595945
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,16884,68,1.18 [0.82-1.70],0.3713217528933221
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20591,3775,1.12 [1.07-1.18],9.346907561156869e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,16998,182,1.11 [0.88-1.39],0.3940129484660569
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17374,558,1.20 [1.06-1.37],0.0054068627003936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23242,275,1.36 [1.15-1.62],0.000405473788137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23059,92,1.52 [1.15-2.00],0.0032198844718642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,16965,149,1.14 [0.88-1.47],0.3163217545251822
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",16881,65,1.15 [0.78-1.71],0.4701148450697869
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23123,731,1.16 [1.04-1.30],0.0093388084736242
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17117,301,1.35 [1.14-1.61],0.0005484920894889
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17187,371,1.28 [1.09-1.49],0.002043243192422
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17532,716,1.15 [1.02-1.29],0.018610501266456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,16957,141,1.00 [0.76-1.31],0.9917512158929724
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23052,85,1.59 [1.20-2.11],0.001404138816549
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17376,560,1.16 [1.02-1.33],0.0226330518253079
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17200,384,1.03 [0.88-1.22],0.6877134523576326
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21058,67,1.33 [0.94-1.89],0.1123492023739375
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21879,5063,1.11 [1.06-1.16],4.6292236096487545e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22412,20,1.20 [0.61-2.35],0.5946291377222997
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22414,22,1.02 [0.53-1.99],0.9438559179619348
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23130,1739,1.01 [0.93-1.09],0.8716870041630367
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23127,1735,1.01 [0.93-1.08],0.8894621585961187
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22414,22,1.34 [0.73-2.45],0.3424667276118552
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23029,786,1.09 [0.98-1.21],0.1284496951679564
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18410,1594,1.18 [1.09-1.27],3.154301939043914e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23287,257,1.30 [1.08-1.55],0.0047519848622999
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22307,105,1.07 [0.79-1.45],0.6458961934141103
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22317,74,1.19 [0.85-1.69],0.3111508231317615
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22326,83,1.38 [1.02-1.89],0.03955313267792
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",16877,61,0.99 [0.66-1.50],0.9768865423014708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20563,160,1.42 [1.13-1.77],0.0024043188142787
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2451,119,1.39 [1.06-1.81],0.0170350332607419
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2616,315,1.07 [0.90-1.28],0.4427330996848265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20501,98,1.37 [1.03-1.84],0.0329065062134611
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2411,81,1.32 [0.95-1.82],0.0967205288398018
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22530,2127,1.31 [1.23-1.39],8.66555424128815e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22556,354,0.98 [0.82-1.16],0.7749872144439198
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21224,233,1.11 [0.91-1.36],0.3013959464522245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17594,778,1.22 [1.09-1.36],0.0004556131117599
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23177,246,0.94 [0.77-1.16],0.5622388406708871
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22090,267,1.20 [1.00-1.44],0.0549076375263697
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,20441,1473,1.16 [1.07-1.26],0.0002167494534765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22199,376,1.20 [1.03-1.40],0.0227182964649857
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21904,81,1.47 [1.08-1.99],0.0128778153222238
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22065,242,1.54 [1.30-1.83],7.25678995648405e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13638,2262,1.02 [0.95-1.09],0.5543218659678817
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,AV-block,18743,602,1.16 [1.02-1.31],0.0218627854578731
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23224,530,1.13 [0.99-1.29],0.0750142659603789
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiac arrest,11624,248,1.22 [1.00-1.48],0.0499435888200976
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18340,199,1.15 [0.93-1.43],0.1971107633438119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18250,109,1.18 [0.89-1.57],0.2540247201303624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23299,65,1.07 [0.73-1.55],0.7365101673121026
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Conduction disorders,19464,1323,1.05 [0.97-1.15],0.2263166072486342
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21524,2580,1.17 [1.11-1.25],1.4931457053086134e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19605,7586,1.04 [1.01-1.08],0.0257912124365316
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22098,269,0.94 [0.77-1.14],0.522001388571759
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Endocarditis,18226,85,0.99 [0.70-1.39],0.9445936734517212
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22990,1287,1.21 [1.11-1.32],6.313047889583683e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,20785,6622,1.07 [1.03-1.12],0.0002475875674111
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20809,6646,1.08 [1.04-1.12],0.0001115137453195
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23077,105,0.80 [0.58-1.10],0.1724317367039275
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14344,181,1.48 [1.20-1.81],0.0002225764938647
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14328,165,1.78 [1.45-2.18],4.566647930159133e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypotension,23154,1191,1.17 [1.07-1.28],0.0003848035416889
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22254,114,0.81 [0.60-1.11],0.1934038849525506
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21660,2692,1.14 [1.08-1.21],1.3514836165125997e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22879,636,1.17 [1.04-1.32],0.0098660006456787
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18550,409,1.11 [0.95-1.29],0.1967968587576351
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22580,1038,1.14 [1.04-1.25],0.0065462577518702
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19867,899,1.21 [1.10-1.34],0.000156859422869
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23140,214,1.29 [1.06-1.56],0.0123059685041296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23248,362,1.13 [0.96-1.32],0.1499584318457521
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Oesophageal varices,21895,66,0.80 [0.54-1.20],0.2865758914263221
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other aneurysm,21918,95,1.40 [1.05-1.87],0.0211244636980162
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arrhythmias,18615,474,1.20 [1.04-1.37],0.0116958216003628
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21954,131,1.49 [1.17-1.88],0.0010601749411666
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22096,273,1.24 [1.04-1.48],0.0187078878983927
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18337,196,1.05 [0.83-1.31],0.6995392358783756
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other disorders of veins,21922,93,1.03 [0.75-1.43],0.8372990463544571
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21875,46,1.13 [0.73-1.77],0.5756895941394355
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21746,86,0.92 [0.64-1.30],0.6273079657042491
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21931,102,1.00 [0.74-1.36],0.9965674398459196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19359,1218,1.14 [1.05-1.25],0.0028242961758861
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22026,63,1.02 [0.69-1.50],0.933031759942894
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22387,564,1.36 [1.20-1.53],5.583901056672192e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22661,356,1.21 [1.04-1.42],0.0151320097816507
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22315,655,1.18 [1.05-1.33],0.0054055122064395
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11745,369,1.08 [0.91-1.27],0.3862715719407997
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22298,522,1.41 [1.25-1.59],1.617962526317692e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22176,347,0.91 [0.77-1.09],0.3013999574793917
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22794,489,0.94 [0.81-1.09],0.3957562259754934
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23235,697,1.07 [0.95-1.21],0.2511416766087914
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18601,460,0.98 [0.85-1.14],0.8129408629853444
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22659,354,1.21 [1.03-1.42],0.0182919916234148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21875,215,1.12 [0.91-1.38],0.2810522677714233
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22863,723,1.13 [1.00-1.26],0.0421097787945823
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22848,747,1.14 [1.02-1.27],0.0231797651444848
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22234,42,1.21 [0.76-1.91],0.422326745865466
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21936,114,1.08 [0.80-1.44],0.6231584241352824
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22482,239,1.30 [1.07-1.57],0.0069201130562444
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21852,310,1.27 [1.08-1.50],0.0044682556955136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Varicose veins,22205,376,1.03 [0.88-1.22],0.6811312138421264
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21842,75,0.93 [0.64-1.34],0.687445310724877
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23062,765,0.94 [0.83-1.05],0.2623661868046508
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23103,488,0.71 [0.61-0.83],7.803573385202223e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20027,953,1.14 [1.03-1.25],0.0112467382592129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,22631,3557,1.09 [1.04-1.15],0.0006181373318382
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23044,579,0.73 [0.64-0.84],6.342433277818912e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20223,1149,1.22 [1.12-1.33],5.568272049509919e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19157,83,1.01 [0.71-1.43],0.9647736465973956
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Smoking dependency,22670,1495,1.22 [1.13-1.31],1.4571989958938478e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20906,1832,1.09 [1.02-1.17],0.0140132678349881
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Vascular dementia,22794,148,0.86 [0.66-1.13],0.2924057058745163
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Alzheimer disease,23296,298,0.93 [0.77-1.13],0.4780047300521343
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15475,57,1.02 [0.66-1.56],0.9436410620312488
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Bell's palsy,21953,74,1.03 [0.72-1.49],0.8577583262713986
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22212,333,1.16 [0.98-1.37],0.0805816534779562
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral cysts,22906,229,1.00 [0.81-1.23],0.9894595794953294
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23214,354,0.93 [0.78-1.10],0.3910462846116325
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22798,59,1.08 [0.72-1.62],0.6954429373884787
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23278,72,0.95 [0.65-1.38],0.7775725715969388
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22765,88,1.04 [0.74-1.45],0.8247814396402648
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Epilepsy,21710,281,0.99 [0.82-1.20],0.913767955297393
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22767,1338,1.06 [0.97-1.15],0.212747121522029
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23262,674,0.95 [0.83-1.07],0.3818080472239175
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22762,2165,1.03 [0.96-1.10],0.3680699611807039
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Generalized epilepsy,22916,59,1.16 [0.79-1.72],0.4499813473371272
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hemiplegia,23132,272,1.02 [0.84-1.23],0.8318515739654013
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hydrocephalus,22731,54,0.93 [0.60-1.43],0.7283108751840082
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23279,60,1.39 [0.97-2.00],0.0733192031972452
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21899,20,0.73 [0.34-1.55],0.4098201255220042
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21972,93,1.39 [1.04-1.86],0.025484170742011
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Memory loss,22634,118,0.99 [0.74-1.32],0.9312524413036448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Migraine,21623,194,1.05 [0.84-1.32],0.6669551353655361
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23273,175,1.06 [0.84-1.34],0.6258781530518351
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Motor neuron disease,15581,150,1.11 [0.86-1.43],0.4361369789564493
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23189,62,1.10 [0.75-1.61],0.6235551463219082
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22833,954,1.07 [0.97-1.18],0.1806193131602981
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Neurological diseases,22007,3598,1.03 [0.98-1.08],0.2965746660522516
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22970,231,0.87 [0.71-1.08],0.2209511088687042
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22263,384,1.12 [0.96-1.31],0.1510467999794079
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23209,344,1.31 [1.12-1.53],0.0006226266352684
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18261,611,0.99 [0.87-1.12],0.837256643887187
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22755,78,1.09 [0.77-1.55],0.632774807328465
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22824,147,0.97 [0.74-1.26],0.8026490877497668
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22724,136,1.03 [0.78-1.35],0.8456909658995009
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21970,91,1.09 [0.79-1.50],0.6189327750161453
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other headache syndromes,21467,38,0.97 [0.57-1.63],0.8999571917097982
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other neurological diseases,23184,507,1.04 [0.90-1.19],0.6138401530784725
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other sleep disorders,22124,695,1.01 [0.90-1.14],0.850905928466003
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Parkinson's disease,23276,531,0.91 [0.79-1.05],0.1870983573000819
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22703,26,1.09 [0.59-2.01],0.77791871930787
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Restless leg syndrome,23297,48,1.30 [0.86-1.98],0.2141713531522228
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Sleep apnoea,22996,626,1.06 [0.93-1.19],0.3855054699827214
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22919,54,1.09 [0.71-1.66],0.6990792826251903
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23281,173,1.01 [0.80-1.29],0.9122615205235746
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21913,34,0.60 [0.33-1.09],0.0965301621354045
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23296,301,0.94 [0.78-1.14],0.5469976196071411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22763,144,0.87 [0.66-1.14],0.3101667919428524
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22764,86,1.33 [0.98-1.81],0.0692671739939188
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22960,288,1.07 [0.89-1.29],0.4684751964732331
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23100,290,1.30 [1.09-1.54],0.0029354370955678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22446,42,0.63 [0.37-1.07],0.089789380836535
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22465,61,0.89 [0.59-1.34],0.5721820516521138
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23206,45,1.15 [0.73-1.80],0.5583402367032132
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23067,121,1.06 [0.80-1.41],0.6851053065936671
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2415,83,1.28 [0.92-1.77],0.137646217188447
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2944,126,1.38 [1.07-1.78],0.012018340587621
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22771,93,0.93 [0.67-1.31],0.6915958877802308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23057,971,1.15 [1.04-1.27],0.006099817014717
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23001,597,0.95 [0.83-1.09],0.4590518058137766
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22547,143,0.91 [0.69-1.20],0.497627529541239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23225,553,0.98 [0.86-1.12],0.791195024636608
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23294,65,1.16 [0.79-1.68],0.4521256088389623
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23157,485,0.99 [0.85-1.14],0.8585792312966288
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23258,312,1.12 [0.94-1.33],0.2201402349494087
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23208,146,1.09 [0.84-1.41],0.5228230861606719
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22480,76,0.95 [0.66-1.37],0.7748220530398042
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22485,81,0.95 [0.66-1.35],0.7693775637236839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22446,42,0.74 [0.44-1.26],0.265474223271357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23203,667,0.95 [0.84-1.07],0.4064625820777998
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22714,178,0.73 [0.57-0.94],0.0162578472337728
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22702,30,0.97 [0.54-1.75],0.9227731894564524
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23039,93,0.95 [0.68-1.33],0.7613238281649073
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23171,225,1.17 [0.95-1.44],0.1306262244684357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22836,164,0.85 [0.66-1.09],0.2036274262644606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23145,83,0.99 [0.70-1.41],0.9742218807563652
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22989,453,1.13 [0.98-1.31],0.0928416028224464
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22801,123,1.19 [0.91-1.56],0.1957703471393319
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21954,1750,1.11 [1.03-1.19],0.0068675945838759
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23140,194,1.15 [0.92-1.43],0.2263616781085125
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23284,142,1.19 [0.92-1.53],0.1865436941726387
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22804,400,0.93 [0.79-1.09],0.3626378942891795
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23008,62,0.93 [0.62-1.40],0.7283687404627092
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23283,54,1.15 [0.76-1.74],0.5081847516325151
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22477,73,0.98 [0.67-1.43],0.9195532251066848
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22536,132,0.97 [0.74-1.28],0.8320647341241346
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22210,124,1.37 [1.06-1.78],0.0166767128397668
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22724,52,0.92 [0.59-1.44],0.7182320877584185
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22147,61,1.20 [0.81-1.76],0.3612373016382468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22586,50,0.92 [0.58-1.45],0.7119388206335171
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22739,203,0.99 [0.79-1.24],0.9011744302794658
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22519,115,0.96 [0.71-1.30],0.8027327619580998
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22207,121,1.16 [0.88-1.53],0.278569928896729
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22176,90,0.93 [0.66-1.31],0.6896931772024784
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21644,1440,1.11 [1.02-1.21],0.012099907892371
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22461,57,0.91 [0.59-1.40],0.6602656651590633
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23058,380,1.10 [0.94-1.29],0.216099367299668
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22746,68,1.12 [0.77-1.62],0.5443589940309275
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22843,165,1.21 [0.96-1.53],0.0984666489751658
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23123,54,1.12 [0.73-1.71],0.6011590243522695
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23256,119,0.81 [0.60-1.09],0.1650687474863617
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23171,112,1.33 [1.02-1.74],0.0381858184118786
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23117,48,0.85 [0.53-1.36],0.4932807084560865
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23122,53,1.20 [0.79-1.81],0.3875543096545796
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23203,953,1.18 [1.07-1.30],0.000990292222945
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22956,706,1.22 [1.09-1.37],0.0005155518155701
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22376,126,0.99 [0.74-1.31],0.9230343019270468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22333,83,1.10 [0.78-1.54],0.5945503594922612
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute pharyngitis,23093,59,0.95 [0.63-1.43],0.797903105591943
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23215,181,1.08 [0.86-1.36],0.5086379381781607
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23092,58,1.26 [0.85-1.87],0.2440408724418426
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,All influenza,21066,105,1.32 [1.00-1.75],0.0488049590996161
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21063,102,1.34 [1.01-1.78],0.0418909137657881
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15277,102,0.83 [0.59-1.15],0.2573567432252467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Allergic rhinitis,23191,264,0.90 [0.74-1.10],0.3122629299778164
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16242,1398,1.00 [0.92-1.09],0.9104326088239592
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16547,1372,1.00 [0.91-1.09],0.9178290277494144
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22921,146,1.45 [1.15-1.81],0.0014109008125843
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21055,94,1.51 [1.14-1.99],0.0037016327922073
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Bronchiectasis,20256,284,1.19 [1.00-1.43],0.0540240338913539
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20015,43,2.12 [1.51-2.96],1.1949853851507789e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22462,2490,1.07 [1.01-1.14],0.0273515543786884
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21874,75,1.06 [0.75-1.52],0.7313713138981636
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic sinusitis,21955,156,1.30 [1.03-1.63],0.0267265820853665
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23076,1275,1.07 [0.98-1.17],0.1089350021858455
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Deviated nasal septum,21935,136,1.12 [0.87-1.45],0.3779439918470905
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21323,5150,1.07 [1.03-1.12],0.0013181582327259
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22180,381,1.07 [0.92-1.26],0.3736778017060452
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Early onset COPD,22101,300,1.20 [1.03-1.41],0.0233114690814355
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Emphysema,20311,339,1.38 [1.19-1.61],3.481360043871988e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22392,329,1.39 [1.19-1.63],3.0380213926664927e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23059,2098,1.13 [1.06-1.21],0.0003205295934674
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,22419,356,1.45 [1.25-1.68],9.54820621481941e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Later onset COPD,22254,975,1.02 [0.92-1.12],0.7564862058416955
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23279,420,1.01 [0.87-1.18],0.8756850804163501
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Nasal polyp,21935,136,1.14 [0.88-1.47],0.3369870730034507
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23028,980,1.20 [1.09-1.32],0.000256993930311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,23016,2145,1.10 [1.02-1.17],0.0073403469303092
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22650,851,1.03 [0.92-1.14],0.6430879741233806
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other pleural conditions,20934,63,1.22 [0.83-1.78],0.3113914906024002
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23200,431,1.43 [1.25-1.63],2.909669395686355e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23174,1358,1.10 [1.01-1.19],0.0310824935816576
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural effusion,21978,1107,1.09 [0.99-1.20],0.0721897850016762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural plaque,21130,259,1.08 [0.89-1.31],0.4268321011722144
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22798,1837,1.15 [1.07-1.23],0.0001168513159387
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23179,320,0.99 [0.83-1.19],0.9534622873972723
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pneumothorax,21011,140,1.07 [0.82-1.39],0.6045348498482568
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pollen allergy,23283,231,0.93 [0.75-1.15],0.4938920837815977
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pulmonary oedema,22831,62,1.20 [0.82-1.75],0.3532867950713335
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15231,56,1.03 [0.67-1.59],0.892908695708352
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23010,962,1.19 [1.08-1.31],0.0005523294606957
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22065,266,0.90 [0.74-1.10],0.3223508775165914
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Viral pneumonia,21238,277,1.09 [0.90-1.31],0.3875659701792489
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22935,236,0.99 [0.81-1.22],0.9346003275097752
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10148,114,0.95 [0.70-1.29],0.7513983133807628
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16285,86,1.12 [0.81-1.56],0.4876205614042289
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute appendicitis,23168,140,1.00 [0.77-1.31],0.9922700755464762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute gastritis,17613,89,1.37 [1.01-1.86],0.0415657739674946
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis,21974,197,1.17 [0.95-1.45],0.1442769538254487
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute peritonitis,22954,91,0.96 [0.69-1.35],0.8271704027081097
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22425,109,0.72 [0.53-0.99],0.0418594341307065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Barrett oesophagus,18039,515,1.00 [0.87-1.15],0.9937999651085336
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21897,120,1.37 [1.06-1.78],0.0167451984077178
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22900,120,1.36 [1.05-1.77],0.0202185099544142
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholecystitis,21991,214,1.04 [0.84-1.29],0.695174228435383
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholelithiasis,22542,765,1.21 [1.09-1.35],0.0003883214477191
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic gastritis,17789,265,1.02 [0.84-1.24],0.8253983819938435
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21835,58,0.98 [0.65-1.48],0.9291856121822708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23101,129,0.97 [0.74-1.28],0.8543485993078401
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Coeliac disease,21716,93,1.50 [1.13-1.98],0.004474691257506
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Collagenous colitis,21889,48,1.53 [1.05-2.24],0.0271125400957087
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23136,211,1.07 [0.87-1.33],0.504719760004305
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Constipation,23138,1561,1.06 [0.98-1.15],0.1193214455654098
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn disease,21931,90,1.54 [1.16-2.03],0.0025455380180107
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22961,65,1.30 [0.91-1.86],0.1437919116536274
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21917,76,1.61 [1.20-2.15],0.0015501142403713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Dental caries,22664,220,1.20 [0.99-1.47],0.0666567005635072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19715,1894,1.03 [0.96-1.11],0.3574188331785456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of appendix,23198,170,1.07 [0.85-1.36],0.55564911374022
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of liver,23159,843,0.98 [0.88-1.09],0.7294840914838595
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21344,3820,1.08 [1.03-1.14],0.0022169840341773
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22942,498,1.12 [0.98-1.28],0.1038241328066154
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23253,390,1.15 [0.99-1.34],0.0724538447525689
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22552,108,1.32 [1.00-1.73],0.0487946639013708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22417,65,1.09 [0.75-1.60],0.6531585831226474
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22990,1367,1.10 [1.01-1.19],0.0290746500579165
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of tongue,22433,106,1.03 [0.76-1.40],0.8343642745756974
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22941,1164,1.14 [1.04-1.24],0.0045841825047029
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19185,2986,1.06 [1.00-1.12],0.0480086240225145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Duodenal ulcer,17784,260,1.19 [0.99-1.43],0.0691040336154671
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23184,205,1.15 [0.93-1.42],0.2096954494651633
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23223,47,0.85 [0.53-1.37],0.5080454555296212
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22468,152,1.00 [0.78-1.28],0.9816235724622449
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16372,173,1.03 [0.81-1.31],0.8287770167985045
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Functional dyspepsia,17943,419,1.10 [0.95-1.28],0.19493067080526
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastric ulcer,17883,359,1.19 [1.01-1.40],0.0333275633443711
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19631,2107,1.03 [0.96-1.10],0.4035988598430275
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18109,585,1.18 [1.04-1.34],0.0094045906225136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17821,7812,1.06 [1.02-1.10],0.0030621058512729
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,GI-bleeding,22757,1134,1.07 [0.98-1.18],0.1369000718929985
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22488,44,1.18 [0.75-1.84],0.4720153741506471
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17145,1207,0.97 [0.88-1.06],0.4794919651515915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22398,82,0.82 [0.57-1.18],0.2842374281865714
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Hernia,21293,3472,1.02 [0.97-1.08],0.402454169903164
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impacted teeth,23226,44,0.93 [0.57-1.51],0.7624996513522538
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impaction of intestines,16246,47,1.23 [0.79-1.90],0.353284360034223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Inguinal hernia,19433,1612,1.03 [0.95-1.12],0.417924590020491
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18010,189,0.95 [0.75-1.21],0.7040189867911921
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16284,85,0.95 [0.67-1.35],0.7743257768589894
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21729,106,1.54 [1.19-1.99],0.001009772280453
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16463,264,1.07 [0.88-1.30],0.4801544448259194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23254,366,1.02 [0.87-1.20],0.8004626306935939
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22512,671,1.20 [1.07-1.34],0.002164774113176
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22715,874,1.21 [1.09-1.34],0.0002180163485632
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17734,210,1.05 [0.85-1.31],0.6475803215102298
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophagitis,18136,612,1.12 [0.98-1.26],0.0852311802719875
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23245,114,1.15 [0.87-1.53],0.3199589420264686
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17898,77,0.84 [0.57-1.23],0.3685781803615555
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17585,1386,1.08 [0.99-1.17],0.0826955058576199
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22030,253,1.19 [0.98-1.43],0.0735421141567022
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21894,117,1.16 [0.88-1.53],0.2933868273449552
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestine,18024,1825,1.04 [0.97-1.13],0.2466211418868196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,21525,5326,1.05 [1.01-1.10],0.0173986583371753
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22395,180,1.17 [0.94-1.46],0.1644976188634426
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of liver,22987,671,0.98 [0.87-1.11],0.7872599771053085
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18239,715,1.11 [0.99-1.25],0.0710288666536018
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21916,139,0.99 [0.76-1.30],0.9694739492888562
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23186,323,1.18 [1.00-1.40],0.0476582172901734
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18304,780,1.20 [1.08-1.34],0.0010449293853571
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22769,1146,1.07 [0.98-1.17],0.1475709189316458
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22613,169,1.03 [0.81-1.31],0.8273218920634251
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17797,1598,1.07 [0.99-1.16],0.0980556218011718
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19329,1805,1.09 [1.01-1.17],0.0203752998606418
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22409,93,1.07 [0.77-1.47],0.6997739218381804
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22606,765,1.20 [1.08-1.33],0.0010615227036401
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16544,345,1.13 [0.95-1.33],0.1588365971466839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23214,56,0.98 [0.64-1.51],0.9439610168455516
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16667,468,1.08 [0.93-1.25],0.3149647679338507
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21781,158,1.05 [0.82-1.35],0.6937015247481566
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23286,41,1.51 [0.99-2.31],0.0542513975983998
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22456,105,1.32 [1.00-1.75],0.0501451485456667
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Toxic colitis,21884,43,0.97 [0.60-1.58],0.9032985988672676
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17811,287,1.00 [0.83-1.21],0.9985020303461548
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcerative colitis,21987,146,1.26 [0.99-1.61],0.0615442698702111
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21965,124,1.18 [0.90-1.55],0.2197622751764597
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Umbilical hernia,18187,366,0.94 [0.80-1.12],0.5117847076692359
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16353,154,1.08 [0.84-1.40],0.5314122065815077
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ventral hernia,18084,263,1.05 [0.86-1.27],0.6561256597182904
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Volvulus,16270,71,0.81 [0.54-1.20],0.2939979509097626
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23225,311,0.76 [0.63-0.92],0.0043613657357129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22990,68,1.30 [0.92-1.85],0.1355811315981282
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21340,94,1.15 [0.84-1.58],0.3790531146607089
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22576,728,1.00 [0.89-1.13],0.9601377040763122
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22040,192,0.98 [0.79-1.23],0.8911524167963744
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21706,460,1.13 [0.98-1.31],0.0838658839148897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23014,269,1.21 [1.01-1.45],0.0422697787656057
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23211,466,1.21 [1.05-1.39],0.006685950247609
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22790,45,1.36 [0.89-2.08],0.156368737897458
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21848,3102,1.05 [0.99-1.11],0.0846423484195389
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22860,401,1.04 [0.89-1.22],0.5956504578615566
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22750,291,1.08 [0.90-1.29],0.4037479454696716
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22840,992,1.00 [0.90-1.10],0.9924140593068944
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23287,30,1.62 [1.00-2.61],0.0481170856176115
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21267,21,0.89 [0.44-1.80],0.7521169282328131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22515,56,1.09 [0.72-1.66],0.679837826561333
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23009,264,1.21 [1.01-1.45],0.0433808413567267
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21720,474,1.09 [0.95-1.26],0.2205656107856154
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21323,77,1.37 [0.99-1.90],0.0567634352744004
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23233,79,1.32 [0.96-1.82],0.0879041848579674
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22060,212,1.19 [0.97-1.46],0.1013777262776142
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23130,208,0.91 [0.73-1.14],0.4272770142125346
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22815,70,1.23 [0.87-1.74],0.2457001535138927
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21311,65,1.01 [0.68-1.50],0.9538625058058372
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22858,1612,1.14 [1.05-1.23],0.0009981396902018
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21760,514,1.12 [0.97-1.28],0.1189078047953422
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21326,80,1.34 [0.97-1.85],0.0726444060794095
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23211,289,1.02 [0.85-1.23],0.81329073616131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22795,50,1.22 [0.80-1.85],0.3490088639622771
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23175,253,0.96 [0.79-1.18],0.7206098554641029
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23244,330,0.75 [0.62-0.90],0.0020203305654908
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21333,87,1.17 [0.84-1.62],0.3468649450164369
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21516,270,0.96 [0.79-1.17],0.6954682926356283
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23238,324,0.74 [0.61-0.89],0.0016155539095264
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21506,260,1.26 [1.06-1.51],0.0086066953319791
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23272,118,1.32 [1.02-1.72],0.0370536075054204
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20113,88,1.19 [0.87-1.64],0.2713188492708385
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21259,4685,1.04 [0.99-1.09],0.1233922460737796
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19866,3292,1.03 [0.97-1.08],0.3492470442378809
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20094,69,1.07 [0.73-1.55],0.7319143936015023
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20434,148,1.00 [0.78-1.30],0.9701317869051148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20430,144,1.19 [0.93-1.53],0.16090447113436
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23097,65,1.21 [0.84-1.74],0.3109942821592512
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20366,80,0.95 [0.67-1.36],0.7988642902087586
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17425,851,0.99 [0.88-1.10],0.8027222639479312
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23178,142,0.71 [0.53-0.94],0.0161801568083338
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20552,266,1.18 [0.98-1.42],0.0869307562908643
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19827,6135,1.04 [1.00-1.09],0.0348028557562881
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22253,88,0.94 [0.67-1.32],0.7209053620960004
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20190,165,0.93 [0.73-1.20],0.5915557269973897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20451,426,1.05 [0.90-1.22],0.5244707548342717
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22490,2204,1.07 [1.00-1.14],0.0520892960807085
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20377,352,0.83 [0.69-0.99],0.0365943586367492
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20077,52,1.29 [0.87-1.91],0.2105567339211635
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20120,95,0.83 [0.59-1.16],0.2726010689290256
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22994,29,1.17 [0.66-2.05],0.5923263900796883
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18000,1426,1.00 [0.92-1.09],0.9177746829366816
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17533,959,1.12 [1.01-1.23],0.0340272843247545
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23160,946,1.10 [1.00-1.22],0.0621498737693995
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16621,47,0.54 [0.32-0.90],0.0187674705939021
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16651,77,1.08 [0.76-1.55],0.6604649039865654
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20288,263,0.95 [0.78-1.16],0.5911064589057784
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17185,611,1.07 [0.95-1.22],0.2769543557253868
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20329,43,1.25 [0.81-1.95],0.3156202888383939
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20808,522,1.13 [0.99-1.30],0.0653416265680587
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20547,261,1.12 [0.92-1.35],0.247765120170265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17146,572,1.04 [0.91-1.19],0.5277173138531769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20091,66,1.10 [0.75-1.60],0.6358639333214016
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20078,53,1.34 [0.91-1.98],0.139347245851154
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22258,93,1.21 [0.89-1.64],0.2186920487493195
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23012,847,0.98 [0.88-1.09],0.7236847507539793
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22563,398,1.01 [0.86-1.18],0.9313317909465464
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23215,284,1.19 [1.00-1.42],0.051231464839895
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18416,1842,1.06 [0.98-1.14],0.1298004754714174
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16625,51,0.92 [0.58-1.45],0.7197211459089795
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20107,82,1.09 [0.77-1.54],0.6184071240625811
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16626,52,1.39 [0.93-2.07],0.1079042964976449
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16620,46,0.87 [0.54-1.42],0.5886573720635939
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22344,179,1.02 [0.81-1.29],0.8687463636563088
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22325,160,0.99 [0.77-1.28],0.9567160446784322
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23262,81,1.13 [0.81-1.59],0.47140957523765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21788,1502,1.12 [1.04-1.22],0.0041732451040484
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20088,63,1.10 [0.75-1.63],0.6225879872538541
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16614,40,1.05 [0.63-1.74],0.8502652487922205
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20889,603,1.13 [1.00-1.28],0.0582894556028174
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18246,1672,1.02 [0.94-1.10],0.6308178879179945
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23018,53,1.46 [1.00-2.13],0.0515146557995348
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23280,62,1.29 [0.90-1.86],0.16807134342674
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20104,79,0.88 [0.61-1.26],0.4762711929244491
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20987,962,1.13 [1.02-1.24],0.0185391457838416
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20118,93,0.78 [0.55-1.10],0.1629232617708632
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17761,1187,1.11 [1.02-1.22],0.019335010632834
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22246,81,1.01 [0.71-1.43],0.9488271672354868
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20067,42,1.36 [0.87-2.13],0.1755177750381284
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20395,109,0.88 [0.64-1.20],0.4057368363893895
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20517,492,1.05 [0.91-1.20],0.5385910691117155
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23150,185,1.01 [0.80-1.28],0.915542245247837
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20765,479,1.20 [1.04-1.37],0.0103504289504138
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23224,278,1.17 [0.98-1.40],0.091340442417489
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23282,37,1.97 [1.34-2.88],0.000527808917708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20169,144,1.04 [0.81-1.36],0.740458782172916
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19098,560,1.16 [1.02-1.32],0.0249136370652904
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20489,464,1.09 [0.94-1.25],0.2648520819892623
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20342,317,0.80 [0.66-0.96],0.0195444203545748
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16604,30,1.28 [0.74-2.19],0.3742810325002084
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18806,2232,1.12 [1.04-1.19],0.0010798578319695
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17020,446,1.10 [0.95-1.28],0.2015385013608637
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23122,157,0.92 [0.71-1.20],0.5368629676961276
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23227,46,0.93 [0.58-1.49],0.7481103087695355
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21362,46,0.88 [0.55-1.41],0.5865981477395718
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16638,64,1.28 [0.89-1.84],0.1888976296264894
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20370,84,1.34 [0.98-1.84],0.064840548822318
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16866,292,1.24 [1.04-1.47],0.0164924836868456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20295,270,1.09 [0.90-1.32],0.3809348015331043
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20501,215,1.25 [1.02-1.53],0.0329426522379025
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20378,92,1.22 [0.89-1.67],0.2148520943202307
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18490,31,1.01 [0.57-1.76],0.9852294585583854
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23283,38,1.97 [1.35-2.87],0.0004048513976968
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20540,515,1.05 [0.91-1.20],0.5065130684290631
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22983,18,1.67 [0.89-3.11],0.1081232123914143
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22244,2219,1.03 [0.96-1.10],0.436183150593955
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20127,102,1.10 [0.82-1.50],0.5186438946106179
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20780,494,1.05 [0.91-1.21],0.4695821178167245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22264,193,0.93 [0.73-1.17],0.5129888539707104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20409,123,1.12 [0.85-1.48],0.4308515143878813
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21579,1293,1.06 [0.97-1.16],0.1816992612484492
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21104,818,1.13 [1.02-1.26],0.0217836107224418
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20068,43,1.16 [0.73-1.85],0.5359526193530466
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23003,38,1.55 [1.01-2.36],0.0427678109035719
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20142,117,1.23 [0.93-1.61],0.1427195440232296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20046,21,1.76 [1.06-2.94],0.0287265481067552
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16632,58,0.79 [0.51-1.22],0.2793250227730203
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22315,1831,1.17 [1.09-1.25],1.7784186678473435e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22832,398,1.02 [0.87-1.19],0.8232057387214384
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22572,138,1.19 [0.92-1.54],0.1847249101634401
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22001,1517,1.31 [1.22-1.41],1.446741454234904e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23052,85,1.64 [1.24-2.17],0.0005123922239472
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23022,346,1.30 [1.11-1.52],0.0008978406828606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cystitis,20497,209,1.07 [0.86-1.33],0.528650339757235
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Dialysis,20588,104,1.73 [1.36-2.21],8.901922882216553e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22038,3251,1.04 [0.99-1.10],0.1367499551673266
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20967,5456,1.08 [1.03-1.12],0.0007517069237739
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23069,102,1.42 [1.09-1.87],0.0106804306791349
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hydrocele,18994,207,0.90 [0.72-1.13],0.3599547817913189
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,20587,361,1.22 [1.04-1.43],0.013445903423959
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21339,2552,1.07 [1.00-1.14],0.0395501145470165
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19018,231,1.00 [0.81-1.23],0.9946548389324518
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20364,76,1.13 [0.80-1.61],0.4799541074555405
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,18895,108,1.09 [0.81-1.47],0.5665832610729831
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23285,59,1.18 [0.80-1.75],0.3957527963008931
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23289,52,0.68 [0.43-1.09],0.1102646194507094
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22480,2192,1.09 [1.02-1.16],0.0106120341982596
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21219,931,1.14 [1.03-1.26],0.0101680915909119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23223,547,1.34 [1.18-1.51],3.0937401020954e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19093,306,0.99 [0.82-1.18],0.8778180391420372
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19068,281,1.21 [1.01-1.44],0.0402322128029061
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19014,227,0.98 [0.79-1.21],0.8531791259118391
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23281,49,0.98 [0.62-1.55],0.9344949009412862
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21774,1486,1.09 [1.00-1.18],0.038224830854413
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20628,402,1.24 [1.07-1.44],0.0049094395577311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22860,184,1.27 [1.03-1.58],0.0274329251577645
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23023,56,1.36 [0.94-1.98],0.1030569418021624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19047,260,1.12 [0.93-1.36],0.2438750253569417
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23002,2776,1.18 [1.11-1.25],1.9143532404409543e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20299,73,1.29 [0.92-1.82],0.1425034645882545
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20638,154,1.24 [0.98-1.56],0.0775830449179269
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22511,77,1.43 [1.04-1.96],0.0267984934511315
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20576,288,1.00 [0.83-1.20],0.972087535709925
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22948,514,1.07 [0.93-1.23],0.334441582349064
